Featured Research

from universities, journals, and other organizations

Medical management alone may be best treatment course for stroke prevention, study suggests

Date:
September 7, 2011
Source:
Rush University Medical Center
Summary:
Patients with narrowed arteries in the brain who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to medical treatment, according to the initial results from the first, nationwide stroke prevention trial to compare the two treatment options.

Patients with narrowed arteries in the brain who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to medical treatment, according to the initial results from the first, nationwide stroke prevention trial to compare the two treatment options.

The results of the National Institutes of Health (NIH) study called Stenting versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) are published in the online first edition of the New England Journal of Medicine.

Rush University Medical Center is the only hospital in Chicago and one of two sites in Illinois that participated in the clinical trial funded by the National Institute of Neurological Disorders and Stroke (NINDS), which is part of the NIH.

"Stenting was associated with a higher stroke and death rate at 30 days (14.7 percent) versus aggressive medical management alone," said Dr. Shyam Prabhakaran, neurologist and site lead investigator at Rush. "At this time, stenting cannot be supported in routine practice; however, whether subgroups may benefit from this or other interventions in the future needs further study."

"This study provides an answer to the longstanding question of what to do to prevent a devastating second stroke in a high risk population," said Prabhakaran, co-author of the New England Journal of Medicine article. "All patients should be managed aggressively with medications."

The medical regimen used in the study included daily blood-thinning medications and aggressive control of blood pressure and cholesterol.

New enrollment in the study was halted in April because early data indicated that strokes and deaths occurred more significantly among the stented patients at the 30-day mark compared to a group of study participants who received medical management alone.

In addition to the intensive medical program, half of the patients participating in the study received an intervention of a self-expanding stent that widens the major artery in the brain and facilitates blood flow. Study authors suggest one possible explanation for the higher stroke rate in the group that received stents. Patients who have had recent stroke symptoms sometimes have unstable plaque in their arteries which the stent could have dislodged.

The device used in the study, called the Gateway-Wingspan intracranial angioplasty and stenting system, is the only system currently FDA approved for certain high-risk stroke patients.

Study participants were in the highest risk category with blockage or narrowing of the arteries from 70-99 percent. Stroke patients with moderate cerebral arterial blockage (50-69 percent) were excluded because their risk of stroke is low with the usual medical management and because researchers thought this group would be unlikely to benefit from stenting.

The SAMMPRIS trial enrolled 451 patients at 50 hospital sites in the U.S. Study investigators analyzed whether patients had a second stroke or died within 30 days of enrollment, or had a stroke in the same area of the brain from 30 days to the end of follow-up. Patients in the study were between 30 and 80 years of age and had experienced a recent transient ischemic attack, a type of stroke that resolved within 24 hours, or another type of non-disabling stroke, which was caused by a large degree of stenosis in the cerebral artery.

The initial hypothesis was that the addition of intracranial stenting to intensive medical therapy would decrease the risk of stroke of death by 35 percent over two years. Instead, researchers found that 14.7 percent of patients in the stenting group experienced a stroke or died compared to the 5.8 percent of patients treated with drug therapy alone.

The study's design for medical management included a daily dosage of 325 milligrams of aspirin, and 75 milligrams a day of clopidogrel, which is a medication used to prevent blood clots, for 90 days after enrollment. Also, patients received aggressive management of key stroke risk factors including high blood pressure and high levels of low density lipoprotein (LDL), the unhealthy form of cholesterol. All patients also participated in a lifestyle modification program which focused on quitting smoking, increasing exercise, and controlling diabetes and cholesterol.

All patients that participated in the trial will continue to be followed for two years to determine longer-term effects of both interventions.

"The SAMMPRIS study is a call to arms to all physicians caring for patients with this high risk condition. It provides evidence that highly effective medications when used in combination and when strict targets for risk factor modification are met can have substantial stroke prevention benefits," said Prabhakaran.


Story Source:

The above story is based on materials provided by Rush University Medical Center. Note: Materials may be edited for content and length.


Journal References:

  1. Marc I. Chimowitz, Michael J. Lynn, Colin P. Derdeyn, Tanya N. Turan, David Fiorella, Bethany F. Lane, L. Scott Janis, Helmi L. Lutsep, Stanley L. Barnwell, Michael F. Waters, Brian L. Hoh, J. Maurice Hourihane, Elad I. Levy, Andrei V. Alexandrov, Mark R. Harrigan, David Chiu, Richard P. Klucznik, Joni M. Clark, Cameron G. McDougall, Mark D. Johnson, G. Lee Pride, Michel T. Torbey, Osama O. Zaidat, Zoran Rumboldt, Harry J. Cloft. Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis. New England Journal of Medicine, 2011; 110907123845030 DOI: 10.1056/NEJMoa1105335
  2. Joseph P. Broderick. The Challenges of Intracranial Revascularization for Stroke Prevention. New England Journal of Medicine, 2011; 110907082203013 DOI: 10.1056/NEJMe1108394

Cite This Page:

Rush University Medical Center. "Medical management alone may be best treatment course for stroke prevention, study suggests." ScienceDaily. ScienceDaily, 7 September 2011. <www.sciencedaily.com/releases/2011/09/110907171519.htm>.
Rush University Medical Center. (2011, September 7). Medical management alone may be best treatment course for stroke prevention, study suggests. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2011/09/110907171519.htm
Rush University Medical Center. "Medical management alone may be best treatment course for stroke prevention, study suggests." ScienceDaily. www.sciencedaily.com/releases/2011/09/110907171519.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


Intensive Medical Therapy More Effective Than Stenting for Preventing a Second Stroke, Trial Shows

Sep. 8, 2011 Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a ... read more
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins